Status of CHEK2 and p53 in patients with early‑onset and conventional gastric cancer
Julita Machlowska(Jagiellonian University), Robert Sitarz(Medical University of Lublin)
Cited by 18
Related Papers
Gastric cancer: epidemiology, prevention, classification, and treatment
|Cancer Management and Research|2018|1.1k
The Importance of Visceral Hypersensitivity in Irritable Bowel Syndrome—Plant Metabolites in IBS Treatment
|Pharmaceuticals|2023|27
Gastric Cancer: An Up-to-Date Review with New Insights into Early-Onset Gastric Cancer
|Cancers|2024|25
Increased Markers of Oxidative Stress and Positive Correlation Low-Grade Inflammation with Positive Symptoms in the First Episode of Schizophrenia in Drug-Naïve Patients
|Journal of Clinical Medicine|2022|18
Epstein–Barr Virus (EBV) and Human Papilloma Virus (HPV) in Gastric Cancers, with Special Reference to Gastric Cancer at a Young Age—A Pilot Study in Poland
|International Journal of Molecular Sciences|2025|4